| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 5 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | Hungary | 1 | |
| #4 | Netherlands | 1 | |
| #5 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Measurement | |
| #3 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Analysing materials | |
| #3 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Braam Stefan Robbert | 10 |
| #2 | Grandela Ana Catarina Martins | 2 |
| #3 | Kettenhofen Ralf | 2 |
| #4 | Wolters Benjamin | 2 |
| #5 | Bohlen Heribert | 2 |
| #6 | Langenberg Karin | 2 |
| #7 | Benjamin Wolters | 1 |
| #8 | Tertoolen Leon | 1 |
| #9 | Ralf Kettenhofen | 1 |
| #10 | Heribert Bohlen | 1 |
| Publication | Filing date | Title |
|---|---|---|
| NL2019618B1 | In vitro method for providing stem cell derived cardiomyocytes | |
| EP3433355A1 | In vivo method for differentiating human pluripotent stem cells into atrial cardiomyocytes | |
| US2018038846A1 | Assays for measuring cardiotoxicity | |
| US2017159018A1 | Cardiomyocyte maturation | |
| US2016122718A1 | Culture medium composition for maturating cardiomyocytes derived from pluripotent mammalian stem cells |